- Home
- RVMD vs HPE Comparison
RVMD vs HPE Comparison
Compare RVMD & HPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | HPE |
|---|---|---|
| Founded | 2014 | 1939 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 32.7B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | RVMD | HPE |
|---|---|---|
| Price | $154.30 | $43.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 19 |
| Target Price | ★ $140.84 | $26.82 |
| AVG Volume (30 Days) | 2.0M | ★ 14.4M |
| Earning Date | 05-06-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $34,296,000,000.00 |
| Revenue This Year | N/A | $20.37 |
| Revenue Next Year | $533.02 | $5.67 |
| P/E Ratio | ★ N/A | $122.89 |
| Revenue Growth | N/A | ★ 13.84 |
| 52 Week Low | $34.00 | $17.03 |
| 52 Week High | $156.25 | $38.58 |
Technical Indicators
Market Signals| Indicator | RVMD | HPE |
|---|---|---|
| Relative Strength Index (RSI) | 62.04 | 83.82 |
| Support Level | $93.39 | $20.73 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 5.02 | 1.56 |
| MACD | -0.50 | 0.75 |
| Stochastic Oscillator | 81.16 | 94.27 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.